Medichem Manufacturing (Malta) is an API manufacturer based in Malta. It holds 11 active US drug master files and 3 valid CEPs across a filed portfolio of 14 molecules. Its most recent recorded inspection, by US FDA, closed on 23 May 2018 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Hal Far, Malta | Not on file |
| Malta, Malta | 3005427637 |
| Molecule | Regulators | Docs |
|---|---|---|
| Apixaban | SFDA (Saudi Arabia), US FDA | 3 |
| Micafungin | SFDA (Saudi Arabia), US FDA | 3 |
| Rivaroxaban | EDQM, SFDA (Saudi Arabia), US FDA | 3 |
| Voriconazole | EDQM, SFDA (Saudi Arabia) | 2 |
| Ambrisentan | US FDA | 1 |
| Cinacalcet | US FDA | 1 |
| Edaravone | US FDA | 1 |
| Lofexidine | US FDA | 1 |
| Prucalopride | US FDA | 1 |
| Revefenacin | US FDA | 1 |
| Solifenacin Succinate | EDQM | 1 |
| Sugammadex | US FDA | 1 |
| Sunitinib | US FDA | 1 |
| スガマデクスナトリウム | PMDA (Japan) | 1 |
Also appears on these molecule pages
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Ask Fred what the record holds on Medichem Manufacturing (Malta), including filings and inspection history.
Chat with Fred, your AI analystRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.